An Open-Label Study of a Wearable Device Targeting ADHD, Executive Function, and Academic Performance
Brain Sciences · 18.12.2023 · 13 (12) · 1728
DOI: 10.3390/brainsci13121728 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain Sciences, online erschienen am 18.12.2023. Verfasst von Lindsay E Ayearst und 2 weiteren Autor:innen. Beteiligte Einrichtung: Revibe Technologies, 3331 Heritage Trade Dr, Suite 101, Wake Forest, NC 27587, USA. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Revibe Technologies.
Abstract (Originalsprache)
Objective
This was an open-label pilot study to test the feasibility and preliminary efficacy of a wearable digital intervention developed to improve on-task behavior. This was an exploratory study to test for specificity of response on parent- and teacher-reported symptom outcomes in attention and hyperactive/impulsive symptoms, as well as domains of functional impairment, including school behavior and learning and executive function. Method:Participants included 38 children aged 8–12 years with a parent-reported past diagnosis of ADHD. Following baseline ratings from parents (N = 38) and teachers (N = 26), participants wore the device to school for four weeks. Parent and teacher ratings of ADHD symptoms, executive function, and functional impairment were repeated at the end of the four-week intervention period. Results:Statistically significant improvement was seen in the total scores for all parent and nearly all teacher outcomes, with moderate effect size improvements in attention, organization and planning, self-monitoring, school functioning, and teacher-reported academic performance.
Conclusions
Preliminary evidence from this open-label pilot study suggests that having a child interact with a wearable device to self-monitor attention is feasible. This exploratory, open-label pilot study found real-world improvement in functional domains, including academic performance. Future research will require a blinded, randomized, controlled trial using an appropriate sham comparator to confirm these findings.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Revibe Technologies, 3331 Heritage Trade Dr, Suite 101, Wake Forest, NC 27587, USA.
- Cambridge Health Alliance, Harvard University, Boston, MA 02459, USA.
ORCID-Profile: Lindsay E Ayearst, Margaret Danielle Weiss
Förderung
- Revibe Technologies
Zitieren
APA
Ayearst, L. E., Brancaccio, R., & Weiss, M. D. (2023). An Open-Label Study of a Wearable Device Targeting ADHD, Executive Function, and Academic Performance. Brain Sciences, 13(12), 1728. https://doi.org/10.3390/brainsci13121728
Vancouver
Ayearst LE, Brancaccio R, Weiss MD. An Open-Label Study of a Wearable Device Targeting ADHD, Executive Function, and Academic Performance. Brain Sciences. 2023;13(12):1728. doi:10.3390/brainsci13121728
BibTeX
@article{Ayearst2023,
author = {Ayearst, Lindsay E and Brancaccio, Richard and Weiss, Margaret Danielle},
title = {An Open-Label Study of a Wearable Device Targeting ADHD, Executive Function, and Academic Performance},
journal = {Brain Sciences},
year = {2023},
volume = {13},
number = {12},
pages = {1728},
doi = {10.3390/brainsci13121728}
}
EUVIMED